Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Craft, S.
Right arrow Articles by Porte, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Craft, S.
Right arrow Articles by Porte, D., Jr
NEUROLOGY 1998;50:164-168
© 1998 American Academy of Neurology

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease

Relationship to severity of dementia and apolipoprotein E genotype

Suzanne Craft, PhD, Elaine Peskind, MD, Michael W. Schwartz, MD, Gerard D. Schellenberg, PhD, Murray Raskind, MD and Daniel Porte, Jr, MD

From the Geriatric Research, Education, and Clinical Centers (Drs. Craft, Peskind, and Schellenberg), Mental Health Service (Drs. Peskind and Raskind), and Department of Medicine (Drs. Schwartz and Porte), Veteran Affairs Puget Sound Health Care System, Seattle, WA; and the Departments of Psychiatry and Behavioral Sciences (Drs. Craft, Peskind, and Raskind), Medicine (Drs. Schwartz and Porte), Pharmacology (Dr. Schellenberg), and Neurology (Dr. Schellenberg), University of Washington School of Medicine, Seattle, WA.

Address correspondence and reprint requests to Dr. Suzanne Craft, GRECC 182B, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108.

Patients with Alzheimer's disease (AD) have elevations of fasting plasma insulin that are hypothesized to be associated with disrupted brain insulin metabolism. We examined paired fasted plasma and CSF insulin levels in 25 patients with AD and 14 healthy age-matched adults and determined whether insulin levels were related to severity of dementia and apolipoprotein E-{epsilon}4 homozygosity, a known genetic risk factor for AD. The AD patients had lower CSF insulin, higher plasma insulin, and a reduced CSF-to-plasma insulin ratio when compared with healthy adults. The differences were greater for patients with more advanced AD. Patients who were not apolipoprotein E-{epsilon}4 homozygotes had higher plasma insulin levels and reduced CSF-to-plasma ratios, whereas {epsilon}4 homozygotes with AD had normal values. Both plasma and CSF insulin levels are abnormal in AD, and there are metabolic differences among apolipoprotein E genotypes.


Supported by the Department of Veteran Affairs, National Institute of Aging grants AG-10880 (to S.C.), AG-08419 (to M.R.), and AG-05136 (to M.R., E.P., and G.D.S.), Alzheimer's Association IIRG-95-1151 (to S.C.), NS 32273(to M.S.), and DK 12829 (to M.S. and D.P.).

Received March 17, 1997. Accepted in final form July 23, 1997.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
C. T. Kodl and E. R. Seaquist
Cognitive Dysfunction and Diabetes Mellitus
Endocr. Rev., June 1, 2008; 29(4): 494 - 511.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Reger, G. S. Watson, P. S. Green, C. W. Wilkinson, L. D. Baker, B. Cholerton, M. A. Fishel, S. R. Plymate, J.C.S. Breitner, W. DeGroodt, et al.
Intranasal insulin improves cognition and modulates {beta}-amyloid in early AD
Neurology, February 5, 2008; 70(6): 440 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Planel, Y. Tatebayashi, T. Miyasaka, L. Liu, L. Wang, M. Herman, W. H. Yu, J. A. Luchsinger, B. Wadzinski, K. E. Duff, et al.
Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms
J. Neurosci., December 12, 2007; 27(50): 13635 - 13648.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. M. Burns, J. E. Donnelly, H. S. Anderson, M. S. Mayo, L. Spencer-Gardner, G. Thomas, B. B. Cronk, Z. Haddad, D. Klima, D. Hansen, et al.
Peripheral insulin and brain structure in early Alzheimer disease
Neurology, September 11, 2007; 69(11): 1094 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. L. Daubert, M.-Y. Chung, and V. L. Brooks
Insulin resistance and impaired baroreflex gain during pregnancy
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2188 - R2195.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. J. Clodfelder-Miller, A. A. Zmijewska, G. V.W. Johnson, and R. S. Jope
Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency
Diabetes, December 1, 2006; 55(12): 3320 - 3325.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Zhao, B. Teter, T. Morihara, G. P. Lim, S. S. Ambegaokar, O. J. Ubeda, S. A. Frautschy, and G. M. Cole
Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention
J. Neurosci., December 8, 2004; 24(49): 11120 - 11126.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Peila, B. L. Rodriguez, L. R. White, and L. J. Launer
Fasting insulin and incident dementia in an elderly population of Japanese-American men
Neurology, July 27, 2004; 63(2): 228 - 233.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. L. Cummings
Alzheimer's Disease
N. Engl. J. Med., July 1, 2004; 351(1): 56 - 67.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. M. Kanaya, E. Barrett-Connor, G. Gildengorin, and K. Yaffe
Change in Cognitive Function by Glucose Tolerance Status in Older Adults: A 4-Year Prospective Study of the Rancho Bernardo Study Cohort
Arch Intern Med, June 28, 2004; 164(12): 1327 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. A. Evans, and D. A. Bennett
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arch Neurol, May 1, 2004; 61(5): 661 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
N. Rasgon and L. Jarvik
Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2004; 59(2): M178 - 183.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. S. Watson, E. R. Peskind, S. Asthana, K. Purganan, C. Wait, D. Chapman, M. W. Schwartz, S. Plymate, and S. Craft
Insulin increases CSF A{beta}42 levels in normal older adults
Neurology, June 24, 2003; 60(12): 1899 - 1903.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. G. Cook, J. B. Leverenz, P. J. McMillan, J. J. Kulstad, S. Ericksen, R. A. Roth, G. D. Schellenberg, L.-W. Jin, K. S. Kovacina, and S. Craft
Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-{epsilon}4 Allele
Am. J. Pathol., January 1, 2003; 162(1): 313 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
I. Hajjar, J. Schumpert, V. Hirth, D. Wieland, and G. P. Eleazer
The Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M414 - 418.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
L. Gasparini, G. K. Gouras, R. Wang, R. S. Gross, M. F. Beal, P. Greengard, and H. Xu
Stimulation of {beta}-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal {beta}-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling
J. Neurosci., April 15, 2001; 21(8): 2561 - 2570.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
W. A. Banks, S. A. Farr, and J. E. Morley
Permeability of the Blood-Brain Barrier to Albumin and Insulin in the Young and Aged SAMP8 Mouse
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2000; 55(12): 601B - 606.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kalmijn, D. Foley, L. White, C. M. Burchfiel, J. D. Curb, H. Petrovitch, G. W. Ross, R. J. Havlik, and L. J. Launer
Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men : The Honolulu-Asia Aging Study
Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2255 - 2260.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Vekrellis, Z. Ye, W. Q. Qiu, D. Walsh, D. Hartley, V. Chesneau, M. R. Rosner, and D. J. Selkoe
Neurons Regulate Extracellular Levels of Amyloid beta -Protein via Proteolysis by Insulin-Degrading Enzyme
J. Neurosci., March 1, 2000; 20(5): 1657 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. A. Bennett
Diabetes and Change in Cognitive Function
Arch Intern Med, January 24, 2000; 160(2): 141 - 143.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhao, H. Chen, H. Xu, E. Moore, N. Meiri, M. J. Quon, and D. L. Alkon
Brain Insulin Receptors and Spatial Memory. CORRELATED CHANGES IN GENE EXPRESSION, TYROSINE PHOSPHORYLATION, AND SIGNALING MOLECULES IN THE HIPPOCAMPUS OF WATER MAZE TRAINED RATS
J. Biol. Chem., December 3, 1999; 274(49): 34893 - 34902.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. Craft, S. Asthana, J. W. Newcomer, C. W. Wilkinson, I. T. Matos, L. D. Baker, M. Cherrier, C. Lofgreen, S. Latendresse, A. Petrova, et al.
Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose
Arch Gen Psychiatry, December 1, 1999; 56(12): 1135 - 1140.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.